Clinical Trial: A Trial Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult Patients With Palmoplantar Pustulosis

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07923851) titled 'A Trial Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult Patients With Palmoplantar Pustulosis' on Oct. 30.

Brief Summary: The study is being conducted to evaluate the efficacy and safety of SHR-1139 injection.

Study Start Date: Nov., 2026

Study Type: INTERVENTIONAL

Condition: Palmoplantar Pustulosis of Adults

Intervention: DRUG: SHR-1139 Injection

SHR-1139 Injection.

DRUG: SHR-1139 Injection Placebo

SHR-1139 Injection Placebo.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd

Published by HT Digital Content Services with permission from Health Daily Digest....